Access to healthcare

The fight against malaria

For the past 30 years, GSK scientists have been working with other organisations across the globe with the aim to develop what could be the world’s first malaria vaccine.

How we do business

Crowd sourcing new treatments for malaria

New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.

Access to healthcare

Increasing medicine access across the world's poorest nations

GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.

Access to healthcare

No 'silver bullet' to tackle this disease

Dr Sophie Biernaux, talks about GSK's commitment to fighting malaria.

How we do business

Open source: the future of medical discovery

There is growing recognition that no single research body or group has the know-how or resources to tackle the most widespread and persistent diseases. Fortunately, a growing number of scientists are engaged in open source innovation that removes barriers and creates a more transparent environment for medical discovery.

Access to healthcare

Malaria

By the time the second hand on your wristwatch has circled its dial, a child in Africa will have died of malaria.